Drug Shortage Report for CLAVULIN 125 F ORAL SUS

Last updated on 2024-02-14 History
Report ID 171718
Drug Identification Number 01916882
Brand name CLAVULIN 125 F ORAL SUS
Common or Proper name amoxicillin / clavulanate potassium for oral suspension
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) AMOXICILLIN CLAVULANIC ACID
Strength(s) 125MG 31.25MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100ML
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-10-14
Estimated end date 2023-07-07
Actual end date 2023-06-20
Shortage status Resolved
Updated date 2024-02-14
Company comments For emergency supply, contact GSK Customer Service 1-800-387-7374.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-10-14 English Compare

Showing 21 to 21 of 21